- NLNK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.2 million.
- NLNK has traded 51,436 shares today.
- NLNK is down 3.1% today.
- NLNK was up 7.8% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NLNK with the Ticky from Trade-Ideas. See the FREE profile for NLNK NOW at Trade-Ideas More details on NLNK: NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. Currently there are 4 analysts that rate NewLink Genetics a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for NewLink Genetics has been 1.2 million shares per day over the past 30 days. NewLink has a market cap of $925.5 million and is part of the health care sector and drugs industry. The stock has a beta of 0.23 and a short float of 31.2% with 13.38 days to cover. Shares are up 50.4% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.